Market Overview

US Stock Futures Rise Ahead Of Jobless Claims, GDP Data

US Stock Futures Rise Ahead Of Jobless Claims, GDP Data
Related IPI
Stocks Hitting 52-Week Lows
Mid-Afternoon Market Update: Stocks Turn Lower; BroadSoft Shares Rise On Earnings Beat
Potash producers rise as Belarus may revive cooperation with Uralkali (Seeking Alpha)
Related CPWR
Compuware's Topaz Software Helps IT Pros Connect Mobile And Mainframe
Compuware's Chris O'Malley On The Company's New 'Startup Mentality'

Pre-open movers

US stock futures gained in early pre-market trade, ahead of economic data. Data on GDP growth for the second quarter and weekly jobless claims will be released at 8:30 a.m. ET. The pending home sales index for August will be released at 10:00 a.m. ET, while the Kansas City Fed manufacturing index for September will be released at 11:00 a.m. ET. Futures for the Dow Jones Industrial Average surged 17 points to 15,227.00, while the Standard & Poor's 500 index futures rose 2.10 points to 1,687.90. Futures for the Nasdaq 100 index gained 10.75 points to 3,210.75.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.45%, London's FTSE 100 index dropping 1.79% and STOXX Europe 600 Index declining 0.36%. German DAX 30 index fell 0.38% and French CAC 40 Index declined 0.57%.

Asian markets ended mixed today. Japan's Nikkei Stock Average surged 1.22%, China's Shanghai Composite declined 1.94% and Australia's ASX/S&P500 gained 0.34%. Hong Kong's Hang Seng index fell 0.36% and India's Sensex rose 0.19%.

Broker Recommendation

Analysts at BMO Capital downgraded Intrepid Potash (NYSE: IPI) from “market perform” to “underperform.” The target price for Intrepid Potash is set to $11.

Intrepid Potash's shares closed at $16.16 yesterday.

Breaking news

  • Compuware (NASDAQ: CPWR) today announced the pricing of its initial public offering of 6.4 million shares of its wholly-owned subsidiary Covisint Corporation's common stock at a price to the public of $10 per share. To read the full news, click here.
  • Exelixis (NASDAQ: EXEL) today announced that the enrollment target of 960 patients has been reached for COMET-1, the company's phase 3 pivotal trial of cabozantinib in patients with metastatic castration-resistant prostate cancer (mCRPC). To read the full news, click here.
  • Toyota (NYSE: TM) today announced that it will begin exporting U.S.-built* Corolla sedans to 18 countries in Latin America and the Caribbean in 2014. To read the full news, click here.
  • Rogers Communications (NYSE: RCI) and Sprint (NYSE: S) announced today that they have reached an agreement enabling Sprint to bring a comprehensive in-car infotainment and telematics solution to Canadians. To read the full news, click here.

Posted-In: BMO Capital US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (CPWR + EXEL)

View Comments and Join the Discussion!